iCardio.aiiCardio.ai
iCardio.ai

iCardio.ai

AI-powered echocardiographic analysis tools for cardiologists.

2019Active19

About

iCardio.ai develops AI-powered solutions to automate echocardiographic analysis, including EchoMeasure™ for automated echo measurements and CardioVision™ for auto-detecting aortic stenosis. They partner with ultrasound companies to deliver their technology to clinicians and enterprises, aiming to integrate AI into cardiac imaging pipelines. The company also offers data for projects and expert interpretations assisted by AI.

Technology stack

detected 2026-06-12
Est. monthly stack spend~$220/mo
CDN
Cloudflare
EmailGoogle Workspace
Stack
BootstrapWebflow
Analytics
Google Analytics 4
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does iCardio.ai do?

iCardio.ai develops AI-powered solutions to automate echocardiographic analysis, including EchoMeasure™ for automated echo measurements and CardioVision™ for auto-detecting aortic stenosis. They partner with ultrasound companies to deliver their technology to clinicians and enterprises, aiming to integrate AI into cardiac imaging pipelines. The company also offers data for projects and expert interpretations assisted by AI.

How much funding has iCardio.ai raised?

iCardio.ai has raised a total of $1M in funding. The most recent round on record is Bootstrapped.

Where is iCardio.ai headquartered?

iCardio.ai is headquartered in Tel Aviv, Israel.

When was iCardio.ai founded?

iCardio.ai was founded in 2019.

What industry does iCardio.ai operate in?

iCardio.ai operates in Healthcare, Ultrasound, Medical Imaging, HealthTech, MedTech, AI-Driven Protein Design.

How many employees does iCardio.ai have?

iCardio.ai has approximately 19 people on record.